BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1854693)

  • 1. Cis-platinum chemotherapy for ocular basal cell carcinoma.
    Morley M; Finger PT; Perlin M; Weiselberg LR; DeBlasio DS
    Br J Ophthalmol; 1991 Jul; 75(7):407-10. PubMed ID: 1854693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvant chemotherapy.
    Gogia A; Pushker N; Sen S; Bakhshi S
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2479-80. PubMed ID: 23708701
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensive destruction of the eyeball by invasion of basal cell carcinoma of the eyelid.
    Jeong S; Yang KJ; Park YG
    Jpn J Ophthalmol; 1999; 43(4):300-2. PubMed ID: 10482476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids.
    Neudorfer M; Merimsky O; Lazar M; Geyer O
    Ann Ophthalmol; 1993 Jan; 25(1):11-3. PubMed ID: 8427483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues.
    Luxenberg MN; Guthrie TH
    Ophthalmology; 1986 Apr; 93(4):504-10. PubMed ID: 3703526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destruction of the orbit and globe by recurrence of basal cell carcinoma.
    Chew R
    Optometry; 2007 Jul; 78(7):344-51. PubMed ID: 17601572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for invasive squamous cell carcinoma of the conjunctiva: A case report.
    Nair AG; Kaliki S; Mishra DK; Reddy VA; Naik MN
    Indian J Ophthalmol; 2015 Dec; 63(12):927-9. PubMed ID: 26862101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of eyelid and peritorbital tumors.
    Luxenberg MN; Guthrie TH
    Trans Am Ophthalmol Soc; 1985; 83():162-80. PubMed ID: 3832525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
    Soysal HG; Soysal E; Markoç F; Ardiç F
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.
    Demirci H; Worden F; Nelson CC; Elner VM; Kahana A
    Ophthalmic Plast Reconstr Surg; 2015; 31(6):463-6. PubMed ID: 25675162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis.
    Murthy R; Honavar SG; Burman S; Vemuganti GK; Naik MN; Reddy VA
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):307-9. PubMed ID: 16052148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival "ring" recurrence of Basal cell carcinoma of the globe.
    Lee S; Cnaan RB; Paramanathan N; Davies M; Benger R; Ghabrial R
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):117-8. PubMed ID: 20305512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
    Madge SN; Khine AA; Thaller VT; Davis G; Malhotra R; McNab A; O'Donnell B; Selva D
    Ophthalmology; 2010 Nov; 117(11):2222-8. PubMed ID: 20570356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orbital exenteration of tumoral origin].
    De Faria A; Alketbi M; Podeur P; Lagier J; Martel A
    J Fr Ophtalmol; 2019 Jun; 42(6):678-680. PubMed ID: 31027855
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary basosquamous carcinoma of the lower eyelid with ocular invasion A case report.
    Papadopoulos GO; Charitonidi E; Filippou N; Fanidou D; Filippou D; Scandalakis P
    Ann Ital Chir; 2018 Mar; 7():. PubMed ID: 29626183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital hyperostosis following exenteration.
    Fleming JC; Linder JS; Karcioglu ZA
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):378-82. PubMed ID: 18806659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vismodegib for periocular and orbital basal cell carcinoma.
    Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
    JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent eyelid basal cell carcinoma with sclerochoroidal infiltration: echographic findings.
    Mantovani E; Doro D; Milizia E; Steindler P
    Ophthalmologica; 1998; 212 Suppl 1():40-1. PubMed ID: 9730747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.